Skip to main content
. 2022 Jun 27;5(6):e2218753. doi: 10.1001/jamanetworkopen.2022.18753

Table 1. Characteristics of the Patient Cohort From 2001 Primary Care Encounters, Stratified by Receipt vs Nonreceipt of Fundoscopy at Least Once in 2019.

Characteristic Overall (N = 767) Received ≥1 PCP fundoscopic examination Odds ratio (95% CI) P valuea
No (n = 674) Yes (n = 93) Unadjusted Adjusted
Age at first visit, median (IQR), y 64 (54-71) 64 (55-71) 60 (52-70) 0.86 (0.72-1.03)b NA NA
Sex, No. (%)
Female 387 (50.5) 343 (50.9) 44 (47.3) 1 [Reference] NA NA
Male 380 (49.5) 331 (49.1) 49 (52.7) 1.15 (0.75-1.79) NA NA
Race, No (%)
African American or Black 297 (38.7) 267 (39.6) 30 (32.3) 0.74 (0.46-1.19) NA NA
Alaska Native or American Indian 1 (0.1) 1 (0.2) 0 NAc NA NA
Asian 29 (3.8) 25 (3.7) 4 (4.3) 1.06 (0.30-2.86) NA NA
Native Hawaiian or Pacific Islander 2 (0.3) 1 (0.2) 1 (1.1) NAc NA NA
White 404 (52.7) 351 (52.1) 53 (57.0) 1 [Reference] NA NA
≥1 Race 16 (2.1) 13 (1.9) 3 (3.2) NAc NA NA
Otherd 10 (1.3) 10 (1.5) 0 1.28 (0.46-3.02) NA NA
Not reported 8 (1.0) 6 (0.9) 2 (2.2) NAc NA NA
Ethnicity, No (%)
Hispanic 17 (2.2) 13 (1.9) 4 (4.3) 2.29 (0.63, 6.65) NA NA
Non-Hispanic 727 (94.8) 641 (95.1) 86 (92.5) 1 [Reference] NA NA
Not reported 23 (3.0) 20 (3.0) 3 (3.2) 1.12 (0.26-3.35) NA NA
Insurance type at first visit
Commercial 361 (47.1) 309 (45.8) 52 (55.9) 1 [Reference] NA NA
Medicare Advantage 183 (23.9) 165 (24.5) 18 (19.4) 0.65 (0.36-1.12) NA NA
Medicare 199 (25.9) 180 (26.7) 19 (20.4) 0.63 (0.35-1.08) NA NA
Medicaid 19 (2.5) 16 (2.4) 3 (3.2) 1.11 (0.25-3.49) NA NA
Tricare 5 (0.7) 4 (0.6) 1 (1.1) 1.49 (0.08-10.3) NA NA
Yearly mean HbA1c level, median (IQR), % of total Hb 6.83 (6.35-7.65) 6.83 (6.30-7.70) 6.85 (6.55-7.25) 0.93 (0.77-1.10) NA NA
Taking insulin at any point in 2019, No. (%)
No 605 (78.9) 532 (78.9) 73 (78.5) 1 [Reference] NA NA
Yes 162 (21.1) 142 (21.1) 20 (21.5) 1.03 (0.59-1.71) NA NA
No. of encounters per patient, median (IQR) 2 (1-3) 2 (2-3) 2 (1-4) 1.01 (0.88-1.14) NA NA
Type of diabetes
Type 1 30 (3.9) 27 (4.0) 3 (3.2) 0.80 (0.19-2.32) NA NA
Type 2 737 (96.1) 647 (96.0) 90 (96.8) 1 [Reference] NA NA
Eye concern reported at any PCP encounter, No. (%) 33 (4.3) 31 (4.6) 2 (2.2) 0.46 (0.07-1.54) NA NA
≥1 Eye care professional examination documented in 2019 by PCP
Up-to-date 466 (60.8) 404 (59.9) 62 (66.7) 1 [Reference] 1 [Reference] NA
Not up-to-date 156 (20.3) 145 (21.5) 11 (11.8) 0.94 (0.89-1.00) 0.56 (0.27-1.08) .10
Not documented 145 (18.9) 125 (18.5) 20 (21.5) 1.00 (0.95-1.07) 0.97 (0.54-1.69) .92

Abbreviations: HbA1c, hemoglobin A1c; NA, not applicable; PCP, primary care professional.

SI conversion factor: To convert HbA1c to a proportion of total Hb, multiply by 0.01.

a

Values are from the multivariable model, which included years in practice of PCP; PCP credential; rural clinic location; whether eye care professional examination was documented as up-to-date, documented as not up-to-date, or not documented; and clinic location in a primary care shortage area.

b

Per 10 years of age.

c

Alaska Native or American Indian, more than 1 race, Native Hawaiian or Pacific Islander, and patients for whom race was not reported were combined with the Other group into a single group for regression analysis because group sizes were so small as to lead to issues with perfect separation with this covariate.

d

The Duke Enterprise Data Unified Content Explorer was used to collect patient racial and ethnic information, which was based on patient self-report. In that system, patients could self-identify as other.